News Teva Pharmaceutical Industries Limited

Equities

TEVA

US8816242098

Market Closed - Nyse Other stock markets 04:00:02 2024-05-09 pm EDT			5-day change	1st Jan Change
16 ^USD	+1.65%		+13.64%	+53.26%

May. 08	Sector Update: Health Care Stocks Slipping Wednesday Afternoon	MT
May. 08	Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-749 as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia	May. 09	AQ
Teva Pharmaceutical Industries : Immediate Report	May. 08	PU
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	May. 08	MT
Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed	May. 08	MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	May. 08	MT
Sector Update: Health Care	May. 08	MT
Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed	May. 08	MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 Revenue $3.82B	May. 08	MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 EPS $0.48	May. 08	MT
Transcript : Teva Pharmaceutical Industries Limited, Q1 2024 Earnings Call, May 08, 2024	May. 08
Teva Pharm Q1 profit falls short of estimates, revenue gains	May. 08	RE
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook	May. 08	BU
Teva Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Teva Pharmaceutical Industries Limited Reports Impairment of Long-Lived Assets for the Three Months Ended March 31, 2024	May. 08	CI
Teva Pharmaceutical Industries Limited Reaffirms Earnings Guidance for the Full Year 2024	May. 08	CI
Teva's 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets	May. 03	AQ
Teva to Present at the 2024 Bank of America Healthcare Conference	May. 02	BU
Teva’s 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets	May. 02	BU
Alvotech - U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-FreeInterchangeable Biosimilar to Humira	May. 01	AQ
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	Apr. 30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 04:41 am EST

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 02, 2023 at 03:19 pm EDT